American Thrombosis and Hemostasis

HICKORY, NC EIN: 20-5244339

The American Thrombosis and Hemostasis Network (ATHN) is a 501(c)(3) nonprofit organization dedicated to advancing and improving care for individuals affected by bleeding and thrombotic disorders. Headquartered in Rochester, New York, with additional operations in Hickory, North Carolina, ATHN operates as a medical research organization classified under heart and circulatory system diseases and disorders.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$5.2M

-5.1% YoY

Annual Giving

$4.8M

+9.4% YoY

Grant Count

71

+57.8% YoY

Avg Grant Size

$68K

-30.6% YoY

Research compiled by Grantable AI from public sources. Last updated April 2026.

Mission & Focus Areas

ATHN is committed to advancing and improving care for individuals affected by bleeding and thrombotic disorders through data management, research support, and outcome measurement. The organization manages a secure national database of patient health data that supports clinical outcomes analysis, research initiatives, advocacy efforts, and public health reporting within the hemostasis and thrombosis community.

Primary Research Programs:

ATHN Transcends — The world's largest natural history study of people affected by non-neoplastic hematologic conditions. Created in response to the National Heart, Lung, and Blood Institute's (NHLBI) Blueprint for Factor VIII Inhibitor Clinical Trials, this program aims to determine the safety of all therapies utilized in this population. The study architecture is designed to encourage the creation of modules exploring specific safety and effectiveness endpoints.

ATHN Research Biorepository — Located at Versiti, Blood Center of Wisconsin, this facility stores biospecimens from ATHN Transcends for future research purposes.

Community Counts CDC Public Health Surveillance Project — A cooperative agreement with the Centers for Disease Control and Prevention (CDC) that gathers uniform demographic and health services utilization data for populations with bleeding and clotting disorders while monitoring related health indicators.

Grantmaking

ATHN reported total giving of $4,715,723 in 2023. The organization functions both as a grantmaker and as a research support entity that facilitates funding opportunities through its network of affiliated treatment centers.

Ready to take the next step with American Thrombosis and Hemostasis?

Geographic Focus

Where this funder awards grants

ATHN operates a national network spanning all 50 states, with hemophilia treatment center affiliates distributed across the United States. The organization maintains offices in both Rochester, New York and Hickory, North Carolina.

Grant Distribution by State

39states
+31 more states

Cities

AlbanyAlbuquerqueAllentownAltantaAnchorageAnn ArborAtlantaAugustaBaltimoreBostonBronxBuffaloChapel HillCharlotteChicagoCincinnatiClevelandColumbiaColumbusDallas

Financial History

Multi-year comparison from IRS filings

2024 Financial Data:

  • Total Revenue: $15,982,317
  • Total Expenses: $17,011,486
  • Total Assets: $5,156,977
  • Number of Employees: 52

2023 Financial Data:

  • Total Revenue: $13.6 million
  • Total Expenses: $16.4 million
  • Total Assets: $5.43 million
  • Total Liabilities: $808,000

Audit Note: An independent audit for the fiscal year ending December 2023 identified a material weakness in internal controls, specifically a deficiency in internal financial or governance controls that could limit the organization's ability to track and report financial data reliably.

Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$5M$9M$14M$19M20202021202220232024
Metric202420232022
Total Assets$5,156,977$5,433,549$8,367,265
Revenue$15,982,317$13,573,899$13,595,220
Expenses$17,011,486$16,433,621$14,534,841
Qualifying Distributions
Net Investment Income$71,496$740,677$101,383
Distributable Amount

Giving Over Time

Total grant dollars and number of grants per year

$0$1M$3M$4M$5M69 grants202064 grants202178 grants202245 grants202371 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

HEMOPHILIA FOUNDATION OF…$567KLEHIGH VALLEY HOSPITAL INC$429KCENTER FOR INHERITED BLO…$394KGREAT LAKES HEMOPHILIA F…$387KICAHN SCHOOL OF MEDICINE…$351KHEMOPHILIA OF GEORGIA$328KOREGON HEALTH & SCIENCE …$292KBOSTON CHILDREN'S HOSPITAL$259KREGENTS UNIVERSITY OF MI…$52KHEMOPHILIA CENTER OF WES…$41K

Grant Size Distribution

245 grants across all recorded years

184<$50K12$50–100K4$100–250K40$250–500K5$500K–1M$1–5M$5M+

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Leadership team and compensation from IRS filings

Key executives include:

  • Moses Miles — Chief Operating Officer
  • Tammuella Chrisentery-Singleton — Chief Science Officer
  • Norma Wolf — Director, Community Counts Surveillance Project

Compensation Overview

From 2024 IRS filing

TAMMUELLA SINGLETONCHIEF SCIENCE OFFICER$406KCRYSTAL WATSONPRESIDENT AND CEO$332KMOSES MILES IIICHIEF OPERATING OFFICER$299KMICHAEL NIEKAMPCFO ENDING 12/24$278KSRIKANTH SUBRAMANYASR. DIRECTOR, ENGINEERING$190KTROY VERBRUGGELEAD SOFTWARE ENGINEER$181KNABIL DAOUDDIRECTOR, DATA SCIENCE$177KJUSTINE KAPLANSR. DIRECTOR, OFFICE OF PHI$167KDIANA VAINSHTEINDIRECTOR, PRODUCT MANAGEMENT$166KROBERT SIDONIO MDDIRECTOR$36KROOSEVELT COUNCILCHIEF FINANCIAL OFFICER$18K

From 2024 filing

NameTitleHoursCompensation
CHRISTOPHER E WALSH MD PHDCHAIR1
TAMARA VOGEL MBATREASURER1
DUC BOBBY TRAN MD MSCDIRECTOR1
JENNIFER G DAVILA MDDIRECTOR1
JIM MUNN RN MSDIRECTOR1
ROBERT SIDONIO MDDIRECTOR1$36,000
CRYSTAL WATSONPRESIDENT AND CEO40$331,645
ROOSEVELT COUNCILCHIEF FINANCIAL OFFICER40$18,073
MICHAEL NIEKAMPCFO ENDING 12/2440$278,341
TAMMUELLA SINGLETONCHIEF SCIENCE OFFICER40$405,584
MOSES MILES IIICHIEF OPERATING OFFICER40$299,312
SRIKANTH SUBRAMANYASR. DIRECTOR, ENGINEERING40$189,553
NABIL DAOUDDIRECTOR, DATA SCIENCE40$177,216
TROY VERBRUGGELEAD SOFTWARE ENGINEER40$181,324
JUSTINE KAPLANSR. DIRECTOR, OFFICE OF PHI40$167,090
DIANA VAINSHTEINDIRECTOR, PRODUCT MANAGEMENT40$166,397

Recent News & Activity

Recent developments and announcements

ATHN has been recognized for its research contributions and partnerships within the hemostasis and thrombosis field. The organization collaborates with professional societies including the Hemostasis and Thrombosis Research Society (HTRS) on initiatives such as the HTRS/ATHN "DREAM" Award, which supports innovative research projects in thrombosis and hemostasis.

ISTH SSC issues new grants to fund innovative new projects in thrombosis

The organization continues to expand its affiliate network and research infrastructure, with ongoing enrollment in ATHN Transcends and active management of its national patient health database to support both clinical care improvement and research advancement.

HTRS/ATHN "DREAM" Award | Hemostasis & Thrombosis Research Society

Subject Areas

Focus areas based on grantmaking activity

Related Funders

Similar funders by location and focus area

Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.

What could you do with American Thrombosis and Hemostasis on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities